Irvine Announces the Opening of an Analytical Facility in Hangzhou, China

Irvine Pharmaceutical Services, Inc. has announced plans to open a new facility in Hangzhou, China. This 115,000sqft. newly built facility will expand Irvine's service offerings into the Asian markets.

Irvine's newest facility is scheduled to be fully operational in the first quarter of 2015. CEO and Founder, Dr. Assad J. Kazeminy explains, "Irvine is responding to the rising needs of large multi-national pharmaceutical companies that are looking for contract organizations overseas that include robust cGMP quality infrastructure and technical expertise. Irvine will now have a local presence and a strong understanding of the local market to offer the region high quality analytical support."